A research study titled, “Radiopharmaceuticals Market by type, procedural volumes and application- global industry analysis and forecast to 2023” published by crystal market research.
Competitive Analysis:The leading players in the market are Bracco Imaging S.p.A, IBA Molecular Imaging India Private Limited, Wipro GE Healthcare Pvt Ltd, Bayer HealthCare Pharmaceuticals LLC, Nordion Inc, Lantheus Medical Imaging Inc, Cardinal Health, Advanced Accelerator Applications and Mallinckrodt.
Competitive Analysis:The leading players in the market are Bracco Imaging S.p.A, IBA Molecular Imaging India Private Limited, Wipro GE Healthcare Pvt Ltd, Bayer HealthCare Pharmaceuticals LLC, Nordion Inc, Lantheus Medical Imaging Inc, Cardinal Health, Advanced Accelerator Applications and Mallinckrodt.
Click to Request a Sample: https://www.crystalmarketresearch.com/report-sample/HC01517
Industry Outlook & Trend Analysis:
The global Radiopharmaceuticals market was worth USD 3.89 billion in 2014 and is expected to reach approximately USD 8.77 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.45% during the forecast period.
The global Radiopharmaceuticals market was worth USD 3.89 billion in 2014 and is expected to reach approximately USD 8.77 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.45% during the forecast period.
The market is right now in its development phase driven by expanding number of disease cases and increasing awareness about nuclear medication. Radiopharmaceuticals are pharmaceutical formulations involving radioactive isotopes that are useful as a part of analysis and therapeutics. They are basic and small substances that contain a radioactive substance that is useful as a part of the treatment of cancer and neurological and cardiac disorders. The regular chemotherapy techniques are being supplanted by more advantageous helpful radiopharmaceuticals for oncology and cancer treatment, which opens up new roads in the radiopharmaceuticals market.
Type Outlook and Trend Analysis
On the basis of type, the market is fragmented into therapeutic and diagnostic. The diagnostic portion represented the biggest share of the nuclear medicine market. The diagnostic portion is additionally fragmented into PET and SPECT. In 2016, the SPECT section represented the biggest share of the radiopharmaceuticals diagnostic market. The therapeutic fragment is additionally divided into brachytherapy, alpha emitters, and beta emitters.
Type Outlook and Trend Analysis
On the basis of type, the market is fragmented into therapeutic and diagnostic. The diagnostic portion represented the biggest share of the nuclear medicine market. The diagnostic portion is additionally fragmented into PET and SPECT. In 2016, the SPECT section represented the biggest share of the radiopharmaceuticals diagnostic market. The therapeutic fragment is additionally divided into brachytherapy, alpha emitters, and beta emitters.
Application Outlook and Trend AnalysisBased on application, the radiopharmaceuticals market is fragmented into PET, SPECT and therapeutic applications. In 2016, the cardiology application section represented the biggest share of the atomic medication SPECT applications market. The atomic radiopharmaceuticals PET applications market was ruled by the oncology section, while the radiopharmaceuticals therapeutic applications market was ruled by the thyroid application fragment.
By Procedural VolumesDiagnostic Procedures
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
Therapeutic Procedures
Beta Emitters
Alpha Emitters
Brachytherapy
Regional Outlook and Trend Analysis
Geographically, the market is fragmented into Europe, North America, Asia-Pacific, and the Rest of the World. North America is accounted for the biggest share, trailed by Asia-Pacific and Europe In 2016. The Asia-Pacific locale is foreseen to develop at the most elevated CAGR amid the estimate time frame. This high development can be ascribed to the establishment of PET scanners in India and activities by the legislature of the Asian nations to advance health among others.
Table of Contents:IntroductionExecutive SummaryMarket OverviewMarket Analysis by RegionMiddle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
North America (U.S, Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
Rest of the World (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates, Others)
Check discount offer for Report click on the link
https://www.crystalmarketresearch.com/check-discount/HC01517
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
Therapeutic Procedures
Beta Emitters
Alpha Emitters
Brachytherapy
Regional Outlook and Trend Analysis
Geographically, the market is fragmented into Europe, North America, Asia-Pacific, and the Rest of the World. North America is accounted for the biggest share, trailed by Asia-Pacific and Europe In 2016. The Asia-Pacific locale is foreseen to develop at the most elevated CAGR amid the estimate time frame. This high development can be ascribed to the establishment of PET scanners in India and activities by the legislature of the Asian nations to advance health among others.
Table of Contents:IntroductionExecutive SummaryMarket OverviewMarket Analysis by RegionMiddle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
North America (U.S, Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
Rest of the World (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates, Others)
Check discount offer for Report click on the link
https://www.crystalmarketresearch.com/check-discount/HC01517
About Crystal Market Research:
Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact Us:
Judy S,
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact Us:
Judy S,
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
No comments:
Post a Comment